Evidence map›Paper›PMID 31565006›Full record

ArticleOpen access rheumatology : research and reviews2019

A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis - results of clinical relevance.

Ingiäld Hafström, Sofia Ajeganova, Maria LE Andersson, Sidona-Valentina Bala, Stefan Bergman, Ann Bremander, Kristina Forslind, Karina Malm, Björn Svensson

Abstract read
In one paragraph

Article in Open access rheumatology : research and reviews, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Influence of Age and Sex on Disease Course and Treatment in Rheumatoid Arthritis.Open access rheumatology : research and reviews · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ingiäld HafströmDivision of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, and Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden.
Sofia AjeganovaDivision of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
Maria LE AnderssonFaculty of Medicine, Department of Clinical Sciences, Rheumatology, Lund University, Lund, Sweden.ORCID 0000-0002-0217-5029
Sidona-Valentina BalaFaculty of Medicine, Department of Health Sciences, Lund University, Lund, Sweden.
Stefan BergmanSpenshult Research and Development Center, Halmstad, Sweden.
Ann BremanderFaculty of Medicine, Department of Clinical Sciences, Rheumatology, Lund University, Lund, Sweden.ORCID 0000-0002-8081-579X
Kristina ForslindFaculty of Medicine, Department of Clinical Sciences, Rheumatology, Lund University, Lund, Sweden.ORCID 0000-0003-1692-9597
Karina MalmSpenshult Research and Development Center, Halmstad, Sweden.
Björn SvenssonFaculty of Medicine, Department of Clinical Sciences, Rheumatology, Lund University, Lund, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAt the end of the twentieth century, the outcome of rheumatoid arthritis (RA) was shown to be unsatisfactory and new therapeutic strategies were introduced. This initiated a register-based long-term study of early RA, the Better Anti-Rheumatic PharmacOTherapy (BARFOT) study. The aims were to evaluate the disease course and to acquire knowledge for improved care. PATIENTS AND

methodsBARFOT is a multicentre observational study of patients with early RA, consecutively included 1992-2006. The patients are followed in daily practice according to a structured protocol for 15 years and data recorded in a web-based register. Also, through linkage of the BARFOT register to national registers we have acquired information on comorbidity and mortality.

resultsIn all, 2857 patients have been included and over 80 scientific articles have been published. Phenotypic characteristics at disease onset, i.e. gender, smoking habits and autoantibody profiles have been addressed. The disease course over 15 years was described. Early predictors for persistent disease activity, impaired function, joint damage and co-morbidities have been identified. Treatment strategies have been studied. A randomized sub-study gave strong support for the treatment of recent RA with low-dose prednisolone in combination with disease-modifying anti-rheumatic drug. Furthermore, the impact of lifestyle factors, such as smoking, alcohol consumption, body weight and physical activity has been addressed.

conclusionA register-based study like BARFOT has provided a basis for optimal long-term management of patients with RA. In addition, the register has made it possible to perform a diversity of studies of RA addressing various issues of major relevance to the patients.

Indexed as

disease progressionlifestyleobservational studypatient reported outcomes, PROprognostic factorsregistry

Identifiers

PMID31565006
PMCPMC6744369

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.